securities fraud

Trip.com faces class action lawsuit alleging failure to disclose regulatory risks tied to monopolistic practices. Investors have until May 11, 2026 to join.

Class action lawsuit filed against Coty Inc. alleging executives made false statements about growth prospects and concealed segment challenges during November 2025-February 2026 period.

Class action lawsuit filed against Aldeyra Therapeutics alleging false statements about reproxalap clinical trial results, covering investors from November 2023 through March 2026.

Class action lawsuit filed against Lakeland Industries for allegedly making false statements about business operations and overstating division performance between December 2023 and December 2025.

Class action lawsuit filed against $CIGL alleging false statements, social media fraud, and insider share dumping between April-July 2025.

Class action lawsuit filed against Alight alleges executives made false statements on growth targets and capital returns. Investors who bought shares November 2024-February 2026 may be eligible; lead plaintiff deadline May 15, 2026.

Boston Scientific faces class action lawsuit alleging material misstatements about U.S. electrophysiology segment. Investors from July 2025-February 2026 may have claims; May 4, 2026 deadline to apply as lead plaintiff.

Disc Medicine ($IRON) shares fell 22% after FDA rejected its bitopertin drug application, prompting class action investigation into securities claims.

Hagens Berman alerts $CORT investors to April 21 lead plaintiff deadline in securities fraud lawsuit over failed relacorilant drug approval and alleged FDA warning concealment.

ADMA Biologics ($ADMA) stock crashed 16.6% following channel stuffing allegations. Rosen Law Firm launches investigation into securities fraud claims.

Class action lawsuit filed against $EOSE for alleged false statements on production capacity and quality control issues. Lead plaintiff deadline: May 5, 2026.

Upstart Holdings faces class action lawsuit alleging false claims about its AI Model 22 risk assessment tool. Investors can join until June 8, 2026.

Stellantis faces class action over allegedly false earnings forecasts and misrepresented EV strategy. Lawsuit covers shareholders who purchased stock between February 2025 and February 2026.

Wolf Haldenstein files class action against $FCHL for alleged market manipulation scheme involving social media fraud that triggered catastrophic stock decline.

Elauwit Connection restates financials due to revenue recognition errors, triggering 6.8% stock decline and spurring class action lawsuit investigation.

$DNOW shares crashed 19.1% after disappointing Q4 results. The Rosen Law Firm investigates potential securities violations on behalf of affected shareholders.

PennyMac Financial Services ($PFSI) plummeted 33.3% after servicing segment income crashed 76% quarter-over-quarter, prompting securities investigation.

Law firm announces class action against Gemini Space Station for allegedly misleading investors about crypto platform viability and international expansion between September 2025 and February 2026.

Class action lawsuit filed against Pinterest alleges false statements on ad revenue, tariff impacts, and undisclosed restructuring. Lead plaintiff deadline set for May 29, 2026.

Class action lawsuit filed against Lufax Holding Ltd alleging securities fraud and inadequate internal controls from April 2023 through January 2025.